A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY
A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:
• suspected prostate cancer warranting standard of care multi-core prostate biopsy
Locations
United States
Florida
HCA Florida Kendall Hospital
RECRUITING
Miami
New York
Icahn School of Medicine at Mount Sinai (ISMMS)
NOT_YET_RECRUITING
New York
Contact Information
Primary
Amy Wu, MD
info@antelopesurgical.com
917-960-8876
Time Frame
Start Date: 2026-07-01
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 10
Treatments
Experimental: Single dose of AS1986NS
Single dose of AS1986NS administered as an injection through peripheral intravenous access.
Related Therapeutic Areas
Sponsors
Leads: Antelope Surgical Solutions, Inc